Strain Information | |
---|---|
Image | |
BRC No. | RBRC09908 |
Type | Targeted Mutation![]() |
Species | Mus musculus |
Strain name | C.Cg-Braf<tm1Tumg> |
Former Common name | Braf Q241R Neo/+ (BALB/c background) |
H-2 Haplotype | |
ES Cell line | Bruce 4 [B6.Cg-Thy1<a>] |
Background strain | BALB/cAnNCrlCrlj |
Appearance | |
Strain development | eveloped by Yoko Aoki and Shin-ichi Inoue, Tohoku University School of Medicine in 2014. BRUCE-4 ES cells were used. B6.Cg-Braf<tm1Tumg>(RBRC09730) was backcrossed to BALB/c for 10 generations. |
Strain description | Knock-in mutants in which Braf-mutated protein (BrafQ241R) is expressed in a Cre-dependent manner. BALB/c genetic background. Q241R mutation in mouse Braf corresponds to Q257R in human BRAF, the most frequent mutation in the cardio-facio-cutaneous (CFC) syndrome. Strains maintained in B6 and 129 genetic background are available as RBRC09730 and RBRC09907, respectively. Mice constitutively expressing BrafQ241R in the ICR genetic background are available as RBRC09731. |
Colony maintenance | |
References | New BRAF knockin mice provide a pathogenetic mechanism of developmental defects and a therapeutic approach in cardio-facio-cutaneous syndrome. Inoue S, Moriya M, Watanabe Y, Miyagawa-Tomita S, Niihori T, Oba D, Ono M, Kure S, Ogura T, Matsubara Y, Aoki Y Hum. Mol. Genet., 23, 6553-6566 (2014). 25035421 |
Health Report | |
---|---|
Examination Date / Room / Rack | 2024/11/25Room:4-BRack:HSentinel mouse program 2024/08/26Room:4-BRack:HSentinel mouse program 2024/05/27Room:4-BRack:HSentinel mouse program |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
Braf MGI:88190 | Braf transforming gene | 6 | Braf<tm1(Q241R)Tumg> | targeted mutation 1, Yoko Aoki | |||
Frt | yeast FRT (flippase recombination target) site | 6 | Frt | ||||
Frt | yeast FRT (flippase recombination target) site | 6 | Frt | ||||
loxP | phage P1 loxP | 6 | loxP | ||||
loxP | phage P1 loxP | 6 | loxP | ||||
neo | neomycin resistance gene (E. coli) | 6 | mouse phosphoglycerate kinase promoter (PGK promoter) | ||||
SV40 polyA signal | 6 |
Phenotype | |
---|---|
Annotation by Mammalian phenotyhpe ontology | |
Detailed phenotype data |
Ordering Information | |
---|---|
Donor DNA | Bacteriophage P1 loxP sites, STOP transcriptional sequence (Adenovirus splice acceptor, SV40 polyA), Saccharomyces cerevisiae FRT sites, Mouse Phosphoglycerate kinase promoter (PGK promoter), E. coli Neomycin resistant gene, Polyomavirus SV40 polyA signal, mouse Braf genomic DNA |
Research application | Cre/loxP system FLP/frt system |
Specific Term and Conditions | In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Hum. Mol. Genet., 23, 6553-6566 (2014).In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. The RECIPIENT agrees to use this BIOLOGICAL RESOURCE as a collaboration with the DEPOSITOR. The RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. |
Depositor | Yoko Aoki (Tohoku University) |
Strain Status | ![]() ![]() ![]() |
Strain Availability | Cryopreserved sperm (within 1 month) Live mouse (3 to 6 months) |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- Mouse of the Month Nov 2022 |
BRC mice in Publications |
---|
No Data |